{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:32Z","timestamp":1707524492601},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,11]]},"DOI":"10.7759\/cureus.22143","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T07:12:11Z","timestamp":1644649931000},"source":"Crossref","is-referenced-by-count":0,"title":["Flavin Adenine Dinucleotide-Related Adverse Event Necessitating Cardiopulmonary Resuscitation in an Infant"],"prefix":"10.7759","author":[{"given":"Shunsuke","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tetsuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzu","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Effects of flavin adenine dinucleotide sodium (FAD) on blood pressure. (Article in Japanese)","volume":"32","author":"Teraoka C","year":"2019","unstructured":"Teraoka C, Asahara A, Fujita K, Hirano S. Effects of flavin adenine dinucleotide sodium (FAD) on blood pressure. (Article in Japanese). Jpn J Dev Pharmacol. 2019, 32:28-32.","journal-title":"Jpn J Dev Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2020.08.001","article-title":"Guidelines for the diagnosis and treatment of acute encephalopathy in childhood","volume":"43","author":"Mizuguchi M","year":"2021","unstructured":"Mizuguchi M, Ichiyama T, Imataka G, et al.. Guidelines for the diagnosis and treatment of acute encephalopathy in childhood. Brain Dev. 2021, 43:2-31. 10.1016\/j.braindev.2020.08.001","journal-title":"Brain Dev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww303","article-title":"Treatable mitochondrial diseases: cofactor metabolism and beyond","volume":"140","author":"Distelmaier F","year":"2017","unstructured":"Distelmaier F, Haack TB, Wortmann SB, Mayr JA, Prokisch H. Treatable mitochondrial diseases: cofactor metabolism and beyond. Brain. 2017, 140:e11. 10.1093\/brain\/aww303","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-014-0292-7","article-title":"Treatment of mitochondrial disorders","volume":"16","author":"Avula S","year":"2014","unstructured":"Avula S, Parikh S, Demarest S, Kurz J, Gropman A. Treatment of mitochondrial disorders. Curr Treat Options Neurol. 2014, 16:292. 10.1007\/s11940-014-0292-7","journal-title":"Curr Treat Options Neurol"},{"key":"ref5","unstructured":"Case list. Information on case reports of suspected side effects. Flavin adenine dinucleotide sodium. (Article in Japanese). (2022). Accessed: January 24, 2022: https:\/\/www.info.pmda.go.jp\/fsearchnew\/fukusayouMainServlet?scrid=SCR_LIST&amp;evt=SHOREI&amp;type=1&amp;pID=3131400&amp;name=%A5%D5%...."},{"key":"ref6","unstructured":"Flavitan injection 5mg\/flavitan injection solution 10mg\/flavitan injection solution 20mg. (Article in Japanese). (2022). Accessed. January 24, 2022: https:\/\/www.info.pmda.go.jp\/go\/pack\/3131400A3127_1_08\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e31805c162a","article-title":"Hemodynamic responses elicited by systemic injections of flavin adenine dinucleotide in anesthetized rats","volume":"50","author":"Hashmi-Hill MP","year":"2007","unstructured":"Hashmi-Hill MP, Graves JE, Sandock K, Bates JN, Robertson TP, Lewis SJ. Hemodynamic responses elicited by systemic injections of flavin adenine dinucleotide in anesthetized rats. J Cardiovasc Pharmacol. 2007, 50:94-102. 10.1097\/FJC.0b013e31805c162a","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0141076814562718","article-title":"The environment and disease: association or causation?","volume":"108","author":"Hill AB","year":"2015","unstructured":"Hill AB. The environment and disease: association or causation?. J R Soc Med. 2015, 108:32-7. 10.1177\/0141076814562718","journal-title":"J R Soc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84615-flavin-adenine-dinucleotide-related-adverse-event-necessitating-cardiopulmonary-resuscitation-in-an-infant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:14Z","timestamp":1707507434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84615-flavin-adenine-dinucleotide-related-adverse-event-necessitating-cardiopulmonary-resuscitation-in-an-infant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.22143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}